Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur Bookman

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
ACR Open Rheumatology|September 30, 2024
Evaluation of Progression From Preclinical to Systemic Autoimmune Rheumatic Disease: Novel Use of the European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria as an Outcome MeasureSindhu R Johnson, Hana Alahmari, Dennisse Bonilla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2025
Differences in IgG Sialylation Distinguish Asymptomatic from Symptomatic Anti-Nuclear Antibody Positive IndividualsCarolina Muñoz-Grajales, Carmen C Ucciferri, Sindhu R Johnson, et al.
Rheumatology (Oxford, England)|June 27, 2021
Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individualsCarolina Muñoz-Grajales, Stephenie D Prokopec, Sindhu R Johnson, et al.
Frontiers in Immunology|July 18, 2022
Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear AntibodiesRashi Gupta, Emma Vanlieshout, Kieran Manion, et al.
Arthritis Research & Therapy|February 11, 2023
Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA<sup>+</sup> individuals without a systemic autoimmune rheumatic disease diagnosisSonya T Kim, Carolina Muñoz-Grajales, Shannon E Dunn, et al.
Arthritis Research & Therapy|November 30, 2018
The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic diseaseYuriy Baglaenko, Nan-Hua Chang, Sindhu R Johnson, et al.
Clinical Rheumatology|December 13, 2006
Office capillaroscopy in systemic sclerosisMurray Baron, Mary Bell, Arthur Bookman, et al.
Lancet (London, England)|August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging studyBenjamin A Fisher, Xavier Mariette, Athena Papas, et al.
RMD Open|October 29, 2015
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guideRaphaèle Seror, Simon J Bowman, Pilar Brito-Zeron, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
ACR Open Rheumatology|September 30, 2024
Evaluation of Progression From Preclinical to Systemic Autoimmune Rheumatic Disease: Novel Use of the European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria as an Outcome MeasureSindhu R Johnson, Hana Alahmari, Dennisse Bonilla, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2025
Differences in IgG Sialylation Distinguish Asymptomatic from Symptomatic Anti-Nuclear Antibody Positive IndividualsCarolina Muñoz-Grajales, Carmen C Ucciferri, Sindhu R Johnson, et al.
Rheumatology (Oxford, England)|June 27, 2021
Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individualsCarolina Muñoz-Grajales, Stephenie D Prokopec, Sindhu R Johnson, et al.
Frontiers in Immunology|July 18, 2022
Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear AntibodiesRashi Gupta, Emma Vanlieshout, Kieran Manion, et al.
Arthritis Research & Therapy|February 11, 2023
Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA<sup>+</sup> individuals without a systemic autoimmune rheumatic disease diagnosisSonya T Kim, Carolina Muñoz-Grajales, Shannon E Dunn, et al.
Arthritis Research & Therapy|November 30, 2018
The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic diseaseYuriy Baglaenko, Nan-Hua Chang, Sindhu R Johnson, et al.
Clinical Rheumatology|December 13, 2006
Office capillaroscopy in systemic sclerosisMurray Baron, Mary Bell, Arthur Bookman, et al.
Lancet (London, England)|August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging studyBenjamin A Fisher, Xavier Mariette, Athena Papas, et al.
RMD Open|October 29, 2015
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guideRaphaèle Seror, Simon J Bowman, Pilar Brito-Zeron, et al.
Pageof 2